SrasV1, Main, Exploration, bibRecord, 004E36

Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum

Identifieur interne : 004E36 ( Main/Exploration ); précédent : 004E35; suivant : 004E37

Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum

Auteurs : S. Chen [République populaire de Chine] ; D. Lu [République populaire de Chine] ; M. Zhang [République populaire de Chine] ; J. Che [République populaire de Chine] ; Z. Yin [République populaire de Chine] ; S. Zhang [République populaire de Chine] ; W. Zhang [République populaire de Chine] ; X. Bo [République populaire de Chine] ; Y. Ding [République populaire de Chine] ; S. Wang [République populaire de Chine]

Source :

European journal of clinical microbiology & infectious diseases : (Print) [ 0934-9723 ] ; 2005.

RBID : Pascal:05-0440639

Descripteurs français

KwdFr :
- Anticorps antiviraux (sang), Humains, Protéines nucléocapside (immunologie), Protéines recombinantes (analyse), Protéines recombinantes (immunologie), Syndrome respiratoire aigu sévère (diagnostic), Syndrome respiratoire aigu sévère (immunologie), Syndrome respiratoire aigu sévère (épidémiologie), Test ELISA, Virus du SRAS (génétique), Virus du SRAS (immunologie), Virus du SRAS (isolement et purification).
MESH :
- analyse : Protéines recombinantes.
- diagnostic : Syndrome respiratoire aigu sévère.
- génétique : Virus du SRAS.
- immunologie : Protéines nucléocapside, Protéines recombinantes, Syndrome respiratoire aigu sévère, Virus du SRAS.
- isolement et purification : Virus du SRAS.
- sang : Anticorps antiviraux.
- épidémiologie : Syndrome respiratoire aigu sévère.
Pascal (Inist)
- Humains, Syndrome respiratoire aigu sévère, Antigène, Anticorps, Sérum, Coronavirus, Homme, Test ELISA.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Antibodies, Viral (blood), Antibody, Antigen, Coronavirus, Enzyme-Linked Immunosorbent Assay, Human, Humans, Nucleocapsid Proteins (immunology), Recombinant Proteins (analysis), Recombinant Proteins (immunology), SARS Virus (genetics), SARS Virus (immunology), SARS Virus (isolation & purification), Serum, Severe Acute Respiratory Syndrome (diagnosis), Severe Acute Respiratory Syndrome (epidemiology), Severe Acute Respiratory Syndrome (immunology), Severe acute respiratory syndrome.
MESH :
- chemical , analysis : Recombinant Proteins.
- chemical , blood : Antibodies, Viral.
- chemical , immunology : Nucleocapsid Proteins, Recombinant Proteins.
- diagnosis : Severe Acute Respiratory Syndrome.
- epidemiology : Severe Acute Respiratory Syndrome.
- genetics : SARS Virus.
- immunology : SARS Virus, Severe Acute Respiratory Syndrome.
- isolation & purification : SARS Virus.
- Enzyme-Linked Immunosorbent Assay, Humans.

Abstract

The study presented here was conducted to evaluate the performance of a double-antigen sandwich ELISA to detect antibodies in human serum against the coronavirus associated with severe acute respiratory syndrome (SARS). A recombinant partial nucleocapsid protein of SARS-associated coronavirus was used as a serodiagnostic antigen in the ELISA. A total of 2892 clinical serum samples were tested with the ELISA kit, which positively identified 25 of 35 (71.4%) samples of patients with confirmed SARS infection, 286 of 407 (70%) samples of patients suspected of having SARS, 229 of 302 (75.8%) samples of convalescent SARS patients, and 0 of 544 samples obtained from healthcare workers; only 1 of 1604 clinical samples obtained from patients with other diseases demonstrated a weakly positive result. These results indicate that the double-antigen sandwich ELISA is an effective screening method for the serodiagnosis of SARS-associated coronavirus.

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum</title>
<author><name sortKey="Chen, S" sort="Chen, S" uniqKey="Chen S" first="S." last="Chen">S. Chen</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1>
<s2>Beijing 100850</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lu, D" sort="Lu, D" uniqKey="Lu D" first="D." last="Lu">D. Lu</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1>
<s2>Beijing 100850</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zhang, M" sort="Zhang, M" uniqKey="Zhang M" first="M." last="Zhang">M. Zhang</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1>
<s2>Beijing 100850</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Che, J" sort="Che, J" uniqKey="Che J" first="J." last="Che">J. Che</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Glodenweikai Medical Biotechnology Co, Ltd</s1>
<s2>Beijing 100850</s2>
<s3>CHN</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Yin, Z" sort="Yin, Z" uniqKey="Yin Z" first="Z." last="Yin">Z. Yin</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Glodenweikai Medical Biotechnology Co, Ltd</s1>
<s2>Beijing 100850</s2>
<s3>CHN</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zhang, S" sort="Zhang, S" uniqKey="Zhang S" first="S." last="Zhang">S. Zhang</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1>
<s2>Beijing 100850</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zhang, W" sort="Zhang, W" uniqKey="Zhang W" first="W." last="Zhang">W. Zhang</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1>
<s2>Beijing 100850</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bo, X" sort="Bo, X" uniqKey="Bo X" first="X." last="Bo">X. Bo</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1>
<s2>Beijing 100850</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ding, Y" sort="Ding, Y" uniqKey="Ding Y" first="Y." last="Ding">Y. Ding</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1>
<s2>Beijing 100850</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wang, S" sort="Wang, S" uniqKey="Wang S" first="S." last="Wang">S. Wang</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1>
<s2>Beijing 100850</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">05-0440639</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0440639 INIST</idno>
<idno type="RBID">Pascal:05-0440639</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000599</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000391</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000662</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000662</idno>
<idno type="wicri:doubleKey">0934-9723:2005:Chen S:double:antigen:sandwich</idno>
<idno type="wicri:Area/Main/Merge">005182</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:16133409</idno>
<idno type="wicri:Area/PubMed/Corpus">002561</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002561</idno>
<idno type="wicri:Area/PubMed/Curation">002561</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002561</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002740</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002740</idno>
<idno type="wicri:Area/Ncbi/Merge">001140</idno>
<idno type="wicri:Area/Ncbi/Curation">001140</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001140</idno>
<idno type="wicri:doubleKey">0934-9723:2005:Chen S:double:antigen:sandwich</idno>
<idno type="wicri:Area/Main/Merge">004B61</idno>
<idno type="wicri:Area/Main/Curation">004E36</idno>
<idno type="wicri:Area/Main/Exploration">004E36</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum</title>
<author><name sortKey="Chen, S" sort="Chen, S" uniqKey="Chen S" first="S." last="Chen">S. Chen</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1>
<s2>Beijing 100850</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lu, D" sort="Lu, D" uniqKey="Lu D" first="D." last="Lu">D. Lu</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1>
<s2>Beijing 100850</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zhang, M" sort="Zhang, M" uniqKey="Zhang M" first="M." last="Zhang">M. Zhang</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1>
<s2>Beijing 100850</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Che, J" sort="Che, J" uniqKey="Che J" first="J." last="Che">J. Che</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Glodenweikai Medical Biotechnology Co, Ltd</s1>
<s2>Beijing 100850</s2>
<s3>CHN</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Yin, Z" sort="Yin, Z" uniqKey="Yin Z" first="Z." last="Yin">Z. Yin</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Glodenweikai Medical Biotechnology Co, Ltd</s1>
<s2>Beijing 100850</s2>
<s3>CHN</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zhang, S" sort="Zhang, S" uniqKey="Zhang S" first="S." last="Zhang">S. Zhang</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1>
<s2>Beijing 100850</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zhang, W" sort="Zhang, W" uniqKey="Zhang W" first="W." last="Zhang">W. Zhang</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1>
<s2>Beijing 100850</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bo, X" sort="Bo, X" uniqKey="Bo X" first="X." last="Bo">X. Bo</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1>
<s2>Beijing 100850</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ding, Y" sort="Ding, Y" uniqKey="Ding Y" first="Y." last="Ding">Y. Ding</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1>
<s2>Beijing 100850</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wang, S" sort="Wang, S" uniqKey="Wang S" first="S." last="Wang">S. Wang</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1>
<s2>Beijing 100850</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">European journal of clinical microbiology & infectious diseases : (Print)</title>
<title level="j" type="abbreviated">Eur. j. clin. microbiol. infect. dis. : (Print)</title>
<idno type="ISSN">0934-9723</idno>
<imprint><date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">European journal of clinical microbiology & infectious diseases : (Print)</title>
<title level="j" type="abbreviated">Eur. j. clin. microbiol. infect. dis. : (Print)</title>
<idno type="ISSN">0934-9723</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Viral (blood)</term>
<term>Antibody</term>
<term>Antigen</term>
<term>Coronavirus</term>
<term>Enzyme-Linked Immunosorbent Assay</term>
<term>Human</term>
<term>Humans</term>
<term>Nucleocapsid Proteins (immunology)</term>
<term>Recombinant Proteins (analysis)</term>
<term>Recombinant Proteins (immunology)</term>
<term>SARS Virus (genetics)</term>
<term>SARS Virus (immunology)</term>
<term>SARS Virus (isolation & purification)</term>
<term>Serum</term>
<term>Severe Acute Respiratory Syndrome (diagnosis)</term>
<term>Severe Acute Respiratory Syndrome (epidemiology)</term>
<term>Severe Acute Respiratory Syndrome (immunology)</term>
<term>Severe acute respiratory syndrome</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Anticorps antiviraux (sang)</term>
<term>Humains</term>
<term>Protéines nucléocapside (immunologie)</term>
<term>Protéines recombinantes (analyse)</term>
<term>Protéines recombinantes (immunologie)</term>
<term>Syndrome respiratoire aigu sévère (diagnostic)</term>
<term>Syndrome respiratoire aigu sévère (immunologie)</term>
<term>Syndrome respiratoire aigu sévère (épidémiologie)</term>
<term>Test ELISA</term>
<term>Virus du SRAS (génétique)</term>
<term>Virus du SRAS (immunologie)</term>
<term>Virus du SRAS (isolement et purification)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Recombinant Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Nucleocapsid Proteins</term>
<term>Recombinant Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Protéines recombinantes</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Protéines nucléocapside</term>
<term>Protéines recombinantes</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>SARS Virus</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Enzyme-Linked Immunosorbent Assay</term>
<term>Humans</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Humains</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Antigène</term>
<term>Anticorps</term>
<term>Sérum</term>
<term>Coronavirus</term>
<term>Homme</term>
<term>Test ELISA</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The study presented here was conducted to evaluate the performance of a double-antigen sandwich ELISA to detect antibodies in human serum against the coronavirus associated with severe acute respiratory syndrome (SARS). A recombinant partial nucleocapsid protein of SARS-associated coronavirus was used as a serodiagnostic antigen in the ELISA. A total of 2892 clinical serum samples were tested with the ELISA kit, which positively identified 25 of 35 (71.4%) samples of patients with confirmed SARS infection, 286 of 407 (70%) samples of patients suspected of having SARS, 229 of 302 (75.8%) samples of convalescent SARS patients, and 0 of 544 samples obtained from healthcare workers; only 1 of 1604 clinical samples obtained from patients with other diseases demonstrated a weakly positive result. These results indicate that the double-antigen sandwich ELISA is an effective screening method for the serodiagnosis of SARS-associated coronavirus.</div>
</front>
</TEI>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
<settlement><li>Pékin</li>
</settlement>
</list>
<tree><country name="République populaire de Chine"><noRegion><name sortKey="Chen, S" sort="Chen, S" uniqKey="Chen S" first="S." last="Chen">S. Chen</name>
</noRegion>
<name sortKey="Bo, X" sort="Bo, X" uniqKey="Bo X" first="X." last="Bo">X. Bo</name>
<name sortKey="Che, J" sort="Che, J" uniqKey="Che J" first="J." last="Che">J. Che</name>
<name sortKey="Ding, Y" sort="Ding, Y" uniqKey="Ding Y" first="Y." last="Ding">Y. Ding</name>
<name sortKey="Lu, D" sort="Lu, D" uniqKey="Lu D" first="D." last="Lu">D. Lu</name>
<name sortKey="Wang, S" sort="Wang, S" uniqKey="Wang S" first="S." last="Wang">S. Wang</name>
<name sortKey="Yin, Z" sort="Yin, Z" uniqKey="Yin Z" first="Z." last="Yin">Z. Yin</name>
<name sortKey="Zhang, M" sort="Zhang, M" uniqKey="Zhang M" first="M." last="Zhang">M. Zhang</name>
<name sortKey="Zhang, S" sort="Zhang, S" uniqKey="Zhang S" first="S." last="Zhang">S. Zhang</name>
<name sortKey="Zhang, W" sort="Zhang, W" uniqKey="Zhang W" first="W." last="Zhang">W. Zhang</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004E36 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004E36 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:05-0440639
   |texte=   Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

Serveur d'exploration SRAS

Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum

Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.